Rational design of substituted diarylureas: a scaffold for binding to G-quadruplex motifs.
暂无分享,去创建一个
Stephen Neidle | Mekala Gunaratnam | Gary N Parkinson | G. Parkinson | S. Neidle | Rupesh K. Nanjunda | W. Wilson | M. Gunaratnam | A. Reszka | Anthony P Reszka | Rupesh Nanjunda | W David Wilson | W. Drewe | William C Drewe | Monica Beltran | Monica Beltran | Wilson Wd | Drewe Wc
[1] Hamid Morjani,et al. Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells* , 2006, Journal of Biological Chemistry.
[2] J. Mergny,et al. Fluorescence Resonance Energy Transfer as a Probe for G‐Quartet Formation by a Telomeric Repeat , 2001, Chembiochem : a European journal of chemical biology.
[3] K. Shin‐ya,et al. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. , 2001, Journal of the American Chemical Society.
[4] Yong Xue,et al. Human telomeric DNA forms parallel-stranded intramolecular G-quadruplex in K+ solution under molecular crowding condition. , 2007, Journal of the American Chemical Society.
[5] R. Gartenhaus,et al. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism , 2007, British Journal of Cancer.
[6] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[7] A. Phan,et al. Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. , 2004, Journal of the American Chemical Society.
[8] Barbara Benassi,et al. Biological Activity of the G-Quadruplex Ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) Is Associated with Telomere Capping Alteration , 2004, Molecular Pharmacology.
[9] S. Neidle,et al. Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. , 2006, Journal of the American Chemical Society.
[10] D. Scudiero,et al. New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.
[11] Stephen Neidle,et al. A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene. , 2006, Biochemistry.
[12] Charles A Laughton,et al. Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. , 2002, Journal of medicinal chemistry.
[13] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[14] C. Dugave. Cis-trans isomerization in biochemistry , 2006 .
[15] D. Osguthorpe,et al. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system , 1988, Proteins.
[16] G. Ortaggi,et al. Specific interactions with intra- and intermolecular G-quadruplex DNA structures by hydrosoluble coronene derivatives: a new class of telomerase inhibitors. , 2007, Bioorganic & medicinal chemistry.
[17] James M. Morrell,et al. Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. , 2004, Bioorganic & medicinal chemistry letters.
[18] W. Hahn,et al. Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.
[19] S. Neidle,et al. Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands. , 2008, Bioorganic & medicinal chemistry letters.
[20] B. Herbert,et al. Telomere dysfunction in aging and cancer. , 2005, The international journal of biochemistry & cell biology.
[21] U. Steiner,et al. Synthesis of caged nucleosides with photoremovable protecting groups linked to intramolecular antennae , 2005 .
[22] John M Sedivy,et al. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.
[23] D. Bearss,et al. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] K. Shin‐ya,et al. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. , 2006, Cancer research.
[25] Sarah W. Burge,et al. Structure of an unprecedented G-quadruplex scaffold in the human c-kit promoter. , 2007, Journal of the American Chemical Society.
[26] C. Harley,et al. Telomerase and cancer therapeutics , 2008, Nature Reviews Cancer.
[27] Roger A. Jones,et al. Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution , 2006, Nucleic acids research.
[28] G. W. Anderson,et al. N,N'-Carbonyldiimidazole, a New Peptide Forming Reagent1 , 1960 .
[29] T. Lange,et al. POT1 as a terminal transducer of TRF1 telomere length control , 2003, Nature.
[30] S. Neidle,et al. Click chemistry assembly of G-quadruplex ligands incorporating a diarylurea scaffold and triazole linkers. , 2008, Chemical communications.
[31] A. Smogorzewska,et al. Regulation of telomerase by telomeric proteins. , 2004, Annual review of biochemistry.
[32] Binh Nguyen,et al. Biosensor-surface plasmon resonance: quantitative analysis of small molecule-nucleic acid interactions. , 2007, Methods.
[33] C. Harley,et al. Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition , 2005, Oncogene.
[34] G. Parkinson,et al. Topology conservation and loop flexibility in quadruplex-drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes. , 2008, Journal of molecular biology.
[35] J. Shay,et al. Telomere-end processing the terminal nucleotides of human chromosomes. , 2005, Molecular cell.
[36] K. Dimitriadis,et al. Optimization of the sulforhodamine B colorimetric assay. , 1997, Journal of immunological methods.
[37] S. Neidle,et al. Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents. , 2007, Bioorganic & medicinal chemistry letters.
[38] Y. Hashimoto,et al. Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2,4(1H,3H)-quinazolinedione skeleton. , 2003, Chemical & pharmaceutical bulletin.
[39] Stephen Neidle,et al. Putative DNA quadruplex formation within the human c-kit oncogene. , 2005, Journal of the American Chemical Society.
[40] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[41] B. Gilchrest,et al. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. , 2004, Experimental cell research.
[42] Stephen Neidle,et al. Structural basis of DNA quadruplex recognition by an acridine drug. , 2008, Journal of the American Chemical Society.
[43] G. Morin. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.
[44] Stephen Neidle,et al. Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.
[45] S. Balasubramanian,et al. Tetrapeptides induce selective recognition for G-quadruplexes when conjugated to a DNA-binding platform. , 2004, Organic & biomolecular chemistry.
[46] S. Neidle,et al. Human telomerase inhibition by substituted acridine derivatives. , 1999, Bioorganic & medicinal chemistry letters.
[47] D. Davies,et al. Helix formation by guanylic acid. , 1962, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Searle,et al. Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. , 2003, Journal of Molecular Biology.
[49] C Roskelley,et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Murnane. Telomeres and chromosome instability. , 2006, DNA repair.
[51] M. Teulade‐Fichou,et al. A hitchhiker's guide to G-quadruplex ligands. , 2008, Organic & biomolecular chemistry.
[52] Stephen Neidle,et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. , 2005, Cancer research.
[53] Kazuo Shin-Ya,et al. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. , 2002, Journal of the American Chemical Society.
[54] A. Phan,et al. Two-repeat human telomeric d(TAGGGTTAGGGT) sequence forms interconverting parallel and antiparallel G-quadruplexes in solution: distinct topologies, thermodynamic properties, and folding/unfolding kinetics. , 2003, Journal of the American Chemical Society.
[55] F. Crick,et al. Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1953, Nature.
[56] E. Blackburn. Switching and Signaling at the Telomere , 2001, Cell.
[57] S Neidle,et al. DNA minor-groove recognition by small molecules. , 2001, Natural product reports.
[58] Stephen Neidle,et al. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. , 2006, Journal of medicinal chemistry.
[59] T. Cech,et al. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection , 2004, Nature Structural &Molecular Biology.
[60] S. Cogoi,et al. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription , 2006, Nucleic acids research.
[61] S. Neidle,et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.
[62] R. Batey,et al. Parallel synthesis of tri- and tetrasubstituted ureas from carbamoyl imidazolium salts. , 2002, Combinatorial chemistry & high throughput screening.
[63] K. Glaser,et al. Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. , 2007, Journal of medicinal chemistry.
[64] R. Moyzis,et al. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[65] Stephen Neidle,et al. A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. , 2004, Molecular cancer therapeutics.
[66] T. Lange,et al. Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .
[67] A. Phan,et al. Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution† , 2007, Nucleic acids research.
[68] B. Guyen,et al. Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors. , 2004, Bioorganic & medicinal chemistry letters.
[69] K. Shin‐ya,et al. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3′ telomeric overhang in cancer cells , 2006, Oncogene.
[70] Shankar Balasubramanian,et al. An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates translation. , 2007, Nature chemical biology.
[71] E. Blackburn,et al. Telomere states and cell fates , 2000, Nature.
[72] J. Mergny,et al. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[73] S. Neidle,et al. Structure-specific recognition of quadruplex DNA by organic cations: influence of shape, substituents and charge. , 2007, Biophysical chemistry.
[74] Sarah W. Burge,et al. Quadruplex DNA: sequence, topology and structure , 2006, Nucleic acids research.
[75] L. Hurley,et al. Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter. , 2006, Journal of the American Chemical Society.
[76] L. Kèlland,et al. Targeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway , 2007, Clinical Cancer Research.
[77] G. Parkinson,et al. Structural basis for binding of porphyrin to human telomeres. , 2007, Biochemistry.
[78] Stephen Neidle,et al. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[79] Shankar Balasubramanian,et al. G-quadruplexes in promoters throughout the human genome , 2006, Nucleic acids research.
[80] D. Loayza,et al. DNA Binding Features of Human POT1 , 2004, Journal of Biological Chemistry.
[81] R. Wheelhouse,et al. Cationic Porphyrins as Telomerase Inhibitors: the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA , 1998 .
[82] J. Langmore,et al. Long G Tails at Both Ends of Human Chromosomes Suggest a C Strand Degradation Mechanism for Telomere Shortening , 1997, Cell.
[83] N. Peet,et al. Phosgenation of methyl anthranilate , 1974 .
[84] A. Phan,et al. Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter , 2005, Nature chemical biology.
[85] L. S. Cram,et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[86] J. Elguero,et al. A New Entry to Bis‐Tröger’s Bases , 2004 .
[87] S Neidle,et al. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. , 1999, Journal of medicinal chemistry.
[88] James M. Morrell,et al. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors. , 2003, Journal of medicinal chemistry.
[89] S. Neidle,et al. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. , 2002, Molecular pharmacology.
[90] T. Duka,et al. First evidence of a functional interaction between DNA quadruplexes and poly(ADP-ribose) polymerase-1. , 2008, ACS chemical biology.